Aytu BioScience Inc (AYTU NASDAQ) stock market data APIs
$2.0314
0(0%)
as of October 8, 2026
Try our APIs with
free plan!
Aytu BioScience Inc Financial Data Overview
Price chart is built with
Anychart
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT A central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 17 years of age; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD in patients 6 to 15 years of age. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Prev. Close
2.0314
Open
2.0653
High
2.0773
Low
2.0266
52 wk Range
1.8-3.07
Market Cap
22 277 K
Shares Outstanding
10 867 K
Revenue
57 570 K
EPS
-0.05
Beta
0.178
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Aytu BioScience Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aytu BioScience Inc data using free add-ons & libraries
Get Aytu BioScience Inc Fundamental Data
Aytu BioScience Inc Fundamental data includes:
- Net Revenue: 57 570 K
- EBITDA: -4 385 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-09-22
- EPS/Forecast: -0.22
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aytu BioScience Inc News
New
Aytu outlines $49M-$54M FY27 operating expense plan as it targets 66%-67% gross margin in Q4 FY27
Earnings Call Insights: Aytu BioPharma (AYTU) Q4 fiscal 2026 MANAGEMENT VIEW * “We finished fiscal 2026 with an encouraging fourth quarter as EXXUA continued to build, our ADHD business performe...
Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates
Aytu BioPharma, Inc. (AYTU) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.26 per share a year ago. These figur...
Aytu BioPharma Q4 2026 Earnings Preview
* Aytu BioPharma (AYTU [https://seekingalpha.com/symbol/AYTU]) is scheduled to announce Q4 earnings results on Monday, September 21st, after market close. * The consensus EPS Estimate is -$0.35 [h...
New Strong Sell Stocks for July 20th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: ACRES Commercial Realty Corp. ACR is a real estate investment trust. The Zacks Consensus Estimate for its current year earni...
Get Aytu BioScience Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.